Slide 1: Analyst and Investor Call
January 17, 2025 Analyst and Investor Call © SUSS
Slide 2: Q4 2024 has been the best quarter in terms of sales and order intake
Investor Presentation Q4 2024 has been the best quarter in terms of sales and order intake in the company's history 147* in € million 45* Order intake by segment; Order intake in € million 102* Q4 2024 150* in € million Sales by segment; 45* in € million Sales 105* Q4 2024 Photomask Solutions Advanc
Slide 3: Order intake by segment (in € m)
Investor Presentation Order intake by segment (in € m) • Strong Q4 2024 order momentum in Book-to-bill ratio FY 2024: 0.94 Photomask Solutions, mainly to support capacity expansion at key customers • Within Advanced Backend Solutions, order intake in Q4 2024 was well 30.0 distributed across the Imag
Slide 4: Order book is a very solid basis for the 2025 financial year
Investor Presentation Order book is a very solid basis for the 2025 financial year Order book as of December 31, 2024, of which the vast majority is expected to be executed in 2025 € 428* million 157* Order book by segment; in € million 271* Photomask Solutions Advanced Backend Solutions * Prelimina
Slide 5: Sales and EBIT margin are expected to exceed 2024 guidance
Investor Presentation Sales and EBIT margin are expected to exceed 2024 guidance Expected financial performance in 2024, based on preliminary, unaudited results (as of January 16, 2025) Sales Gross profit margin EBIT margin in € million in % in % ~445 ~40.0 ~17.5 Actual 2023: Actual 2023: Actual 202
Slide 6: Investor Relations information
Investor Relations information Conference Calendar Financial Calendar January 16, 2025 March 27, 2025 Needham Growth Conference, virtual (IR-only) Annual Report 2024 March 6, 2025 May 8, 2025 Berenberg EU Opportunities Conference, London Q1 Report 2025 April 2, 2025 June 3, 2025 Metzler Small Cap Da
Slide 7: Disclaimer
Investor Presentation Disclaimer This presentation contains forward-looking statements relating to the business. financial performance and earnings of SUSS MicroTec SE and its subsidiaries and associates. Forward-looking statements are based on current plans. estimates. projections and expectations
Slide 8: Thank you
Thank you Growing Innovation Sven Koepsel VP Investor Relations & Communications Tel.: +49 89 32007-151 E-mail: sven.koepsel@suss.com Florian Mangold Manager Investor Relations Tel.: +49 89 32007-306 E-mail: florian.mangold@suss.com 8